US4446315A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Adenosine 5'-triphosphate-4-carboxamide-ribofuranosylthiazole
Assignee: UNITED STATES GOVERNMENT REPRESENTED BY SECRETARY OF DEPARTMENT OF HEALTH AND HUMAN SERVICES
•
Filing: 1982-09-24
•
Granted: 1984-05-01
•
Expires: 2002-09-24
Abstract
Abstract The present invention relates to the preparation of and the antitumor compound, adenosine 5'-(trihydrogen diphosphate) 5'->5'-ester with 4-carboxamide-2- beta -D-ribofuranosylthiazole.
Inventors
- 👤 Victor E. Marquez
- 👤 David A. Cooney
- 👤 Gulilat Gebeyehu
- 👤 Hiremagalur N. Jayaram
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 07:11
CPC Classifications
C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/16; C07H19/20; C07H19/207
Claims Analysis
Total Claims: 2
Claim 1
Independent Claim
9 words
2-β-D-Ribofuranosylthiazole-4-carboxamide 5'→5'-adenosine pyrophosphate and pharmaceutically acceptable acid addition salts.
Claim 2
Dependent Claim
9 words
2-β-D-Ribofuranosylthiazole-4-carboxamide 5'→5'-adenosine pyrophosphate and pharmaceutically acceptable acid addition salts.
References Cited (Backward Citations)
US29835A
Cited
US3493558A
Cited
US3534017A
Cited
US3804826A
Cited
US3798209A
Cited
US3897415A
Cited
US3927216A
Cited
USRE29835E
Cited
US4211771A
Cited
US3976545A
Cited
US4138547A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-05-01 | 1987-10-31 | 1988-05-01 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-05-01 | 1991-10-31 | 1992-05-01 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-05-01 | 1995-10-31 | 1996-05-01 | $7700.00 | Window Closed / Lapsed |